Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FZD3 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | RAB5C | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | EBPL | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | ERGIC3 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | FBXO45 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | GLMP | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | ZNF266 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | GPRC5A | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | PPP4R3A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | TPP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |